Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Munich - Delayed Quote EUR

Cynata Therapeutics Ltd (51S.MU)

Compare
0.1640
0.0000
(0.00%)
As of 8:25:58 AM GMT+1. Market Open.
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
12,545.8120
12,545.8120
16,542.5170
13,838.0440
9,080.3830
Operating Income
-12,545.8120
-12,545.8120
-16,542.5170
-13,838.0440
-9,080.3830
Net Non Operating Interest Income Expense
417.7100
417.7100
352.8690
64.7490
92.2990
Other Income Expense
2,383.3930
2,383.3930
1,912.1530
8,328.1230
1,298.4010
Pretax Income
-9,744.7090
-9,744.7090
-14,277.4950
-5,445.1720
-7,689.6830
Net Income Common Stockholders
-9,744.7090
-9,744.7090
-14,277.4950
-5,445.1720
-7,689.6830
Basic EPS
-0.05
--
-0.10
-0.04
-0.06
Diluted EPS
-0.05
--
-0.10
-0.04
-0.06
Basic Average Shares
179,631.7860
--
145,092.4170
143,276.5940
130,427.0770
Diluted Average Shares
179,631.7860
--
145,092.4170
143,276.5940
130,427.0770
Net Income from Continuing & Discontinued Operation
-9,744.7090
-9,744.7090
-14,277.4950
-5,445.1720
-7,689.6830
Normalized Income
-9,744.7090
-9,744.7090
-14,277.4950
-5,445.1720
-7,689.6830
Interest Income
417.7100
417.7100
352.8690
64.7490
92.2990
Net Interest Income
417.7100
417.7100
352.8690
64.7490
92.2990
EBIT
-12,545.8120
-12,545.8120
-16,542.5170
-13,838.0440
-9,080.3830
EBITDA
-12,265.0800
-12,265.0800
-16,262.5520
-13,558.0790
-8,800.4180
Reconciled Depreciation
280.7320
280.7320
279.9650
279.9650
279.9650
Net Income from Continuing Operation Net Minority Interest
-9,744.7090
-9,744.7090
-14,277.4950
-5,445.1720
-7,689.6830
Normalized EBITDA
-12,265.0800
-12,265.0800
-16,262.5520
-13,558.0790
-8,800.4180
6/30/2021 - 1/5/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers